title: [Buschke-Lowenstein tumor of the anal area].
authors: Service de Dermatologie, Hôpital Bichat, Paris.
authors: P
authors: P
authors: Oberlin
authors: B
authors: B
authors: Crickx
authors: C
authors: C
authors: Picard
authors: G
authors: G
authors: Benhamou
authors: J
authors: J
authors: Vilotte
authors: C
authors: C
authors: Vissuzaine
authors: P
authors: P
authors: Bilbault
authors: S
authors: S
authors: Belaïch
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001005:Anus Neoplasms / Q000473:pathology / Q000628:therapy*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003218:Condylomata Acuminata / Q000473:pathology / Q000628:therapy*; D005050:Etretinate / Q000627:therapeutic use; D005472:Fluorouracil / Q000008:administration & dosage; D015654:Herpesvirus 6, Human / Q000302:isolation & purification; D006716:Homosexuality; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010386:Pelvic Neoplasms / Q000556:secondary*; D011379:Prognosis
chemical_list: D001761:Bleomycin; D005050:Etretinate; D007372:Interferons; D002945:Cisplatin; D005472:Fluorouracil
vernacular_title: Tumeur de Buschke-Löwenstein de la région anale.